A Gauge-fixed Hamiltonian for Lattice QCD

We study the gauge fixing of lattice QCD in 2+1 dimensions, in the Hamiltonian formulation. The technique easily generalizes to other theories and dimensions. The Hamiltonian is rewritten in terms of variables which are gauge invariant except under a single global transformation. This paper extends previous work, involving only pure gauge theories, to include matter fields.Comment: 7 pages of LaTeX, RU-92-45 and BUHEP-92-3

JULES-BE:Representation of bioenergy crops and harvesting in the Joint UK Land Environment Simulator vn5.1

We describe developments to the land surface model JULES, allowing for flexible user-prescribed harvest regimes of various perennial bioenergy crops or natural vegetation types. Our aim is to integrate the most useful aspects of dedicated bioenergy models into dynamic global vegetation models, in order that assessment of bioenergy options can benefit from state-of-the-art Earth system modelling. A new plant functional type (PFT) representing Miscanthus is also presented. The Miscanthus PFT fits well with growth parameters observed at a site in Lincolnshire, UK; however, global observed yields of Miscanthus are far more variable than is captured by the model, primarily owing to the model's lack of representation of crop age and establishment time. Global expansion of bioenergy crop areas under a 2 ?C emissions scenario and balanced greenhouse gas mitigation strategy from the IMAGE integrated assessment model (RCP2.6- SSP2) achieves a mean yield of 4.3 billion tonnes of dry matter per year over 2040-2099, around 30 % higher than the biomass availability projected by IMAGE. In addition to perennial grasses, JULES-BE can also be used to represent short-rotation coppicing, residue harvesting from cropland or forestry and rotation forestry

Theoretical Limits on the Threshold for the Response of Long Cells to Weak Extremely Low Frequency Electric Fields Due to Ionic and Molecular Flux Rectification

AbstractUnderstanding exposure thresholds for the response of biological systems to extremely low frequency (ELF) electric and magnetic fields is a fundamental problem of long-standing interest. We consider a two-state model for voltage-gated channels in the membrane of an isolated elongated cell (Lcell=1mm; rcell=25μm) and use a previously described process of ionic and molecular flux rectification to set lower bounds for a threshold exposure. A key assumption is that it is the ability of weak physical fields to alter biochemistry that is limiting, not the ability of a small number of molecules to alter biological systems. Moreover, molecular shot noise, not thermal voltage noise, is the basis of threshold estimates. Models with and without stochastic resonance are used, with a long exposure time, texp=104 s. We also determined the dependence of the threshold on the basal transport rate. By considering both spherical and elongated cells, we find that the lowest bound for the threshold is Emin ≈ 9×10−3 V m−1 (9×10−5 V cm−1). Using a conservative value for the loop radius rloop=0.3m for induced current, the corresponding lower bound in the human body for a magnetic field exposure is Bmin ≈ 6×10−4 T (6G). Unless large, organized, and electrically amplifying multicellular systems such as the ampullae of Lorenzini of elasmobranch fish are involved, these results strongly suggest that the biophysical mechanism of voltage-gated macromolecules in the membranes of cells can be ruled out as a basis of possible effects of weak ELF electric and magnetic fields in humans

Microfabrication of Individual 200μm Diameter Transdermal Microconduits Using High Voltage Pulsing in Salicylic Acid and Benzoic Acid

We describe an extension of semiconductor fabrication methods that creates individual ≈ 200;μm diameter aqueous pathways through human stratum corneum at predetermined sites. Our hypothesis is that spatially localized electroporation of the multilamellar lipid bilayer membranes provides rapid delivery of salicylic acid to the keratin within corneocytes, leading to localized keratin disruption and then to a microconduit. A microconduit penetrating the isolated stratum corneum supports a volumetric flow of order 0.01;ml per s with a pressure difference of only 0.01;atm (about 102;Pa). This study provides a method for rapidly microengineering a pathway in the skin to interface future devices for transdermal drug delivery and sampling of biologically relevant fluids

Metastatic disease to the breast: the Washington University experience

<p>Abstract</p> <p>Background</p> <p>Metastases to the breast occur rarely, but may be increasing in incidence as patients live longer with malignant diseases. The aim of this study is to characterize metastatic disease to the breast and to describe the management and prognosis of patients who present with this diagnosis.</p> <p>Methods</p> <p>A retrospective review of our institution's pathology and breast cancer databases was performed in order to identify patients with breast malignancies that were not of primary breast origin. Chart review provided additional information about the patients' primary malignancies and course of illness.</p> <p>Results</p> <p>Between 1991 and 2006, eighteen patients with metastatic disease to the breast of non-hematologic origin were identified and all had charts available for review. Among the 18 patients with disease metastatic to the breast, tissues of origin included 3 ovarian, 6 melanoma, 3 medullary thyroid, 3 pulmonary neuroendocrine, 1 pulmonary small cell, 1 oral squamous cell, and 1 renal cell. Overall mean survival after diagnosis of metastatic disease to the breast was 22.4 months. Treatment of metastases varied and included combinations of observation, surgery, radiation, and chemotherapy. Five patients (27.8%) required a change in management of their breast disease for local control.</p> <p>Conclusion</p> <p>Due to the variable course of patients with metastatic disease, a multi-disciplinary approach is necessary for each patient with disease metastatic to the breast to determine optimal treatment. Based on our review, many patients survive for long periods of time and local treatment of metastases to the breast may be beneficial in these patients to prevent local complications.</p

C-LLAMA 1.0: a traceable model for food, agriculture, and land use

We present C-LLAMA 1.0 (Country-level Land Availability Model for Agriculture), a statistical–empirical model of the global food and agriculture system. C-LLAMA uses simplistic and highly traceable methods to provide an open and transparent approach to modelling the sensitivity of future agricultural land use to drivers such as diet, crop yields, and food-system efficiency. C-LLAMA uses publicly available FAOSTAT food supply, food production, and crop yield data to make linear projections of diet, food-system, and agricultural efficiencies, as well as land use at a national level, aiming to capture aspects of food systems in both developing and developed nations. In this paper we describe the structure and processes within the model, outline an anchor scenario, and perform sensitivity analyses of key components. The model land use output behaves as anticipated during sensitivity tests and under a scenario with a prescribed reduction in animal product consumption, in which land use for agriculture is reduced by 1.8 Gha in 2050 when compared with the anchor scenario

Long-term collaboration reaps dividends for clinical research in chronic movement disorders.

Poster presented at the Clinical Trials Symposium, RD&E Exeter, 5/11/15

Glycine supplementation extends lifespan of male and female mice.

Diets low in methionine extend lifespan of rodents, though through unknown mechanisms. Glycine can mitigate methionine toxicity, and a small prior study has suggested that supplemental glycine could extend lifespan of Fischer 344 rats. We therefore evaluated the effects of an 8% glycine diet on lifespan and pathology of genetically heterogeneous mice in the context of the Interventions Testing Program. Elevated glycine led to a small (4%-6%) but statistically significant lifespan increase, as well as an increase in maximum lifespan, in both males (p = 0.002) and females (p \u3c 0.001). Pooling across sex, glycine increased lifespan at each of the three independent sites, with significance at p = 0.01, 0.053, and 0.03, respectively. Glycine-supplemented females were lighter than controls, but there was no effect on weight in males. End-of-life necropsies suggested that glycine-treated mice were less likely than controls to die of pulmonary adenocarcinoma (p = 0.03). Of the 40 varieties of incidental pathology evaluated in these mice, none were increased to a significant degree by the glycine-supplemented diet. In parallel analyses of the same cohort, we found no benefits from TM5441 (an inhibitor of PAI-1, the primary inhibitor of tissue and urokinase plasminogen activators), inulin (a source of soluble fiber), or aspirin at either of two doses. Our glycine results strengthen the idea that modulation of dietary amino acid levels can increase healthy lifespan in mice, and provide a foundation for further investigation of dietary effects on aging and late-life diseases

Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease: a randomized clinical trial

IMPORTANCE It is unclear whether physiotherapy and occupational therapy are clinically effective and cost-effective in Parkinson disease (PD). OBJECTIVE To perform a large pragmatic randomized clinical trial to evaluate the clinical effectiveness of individualized physiotherapy and occupational therapy in PD. DESIGN, SETTING, AND PARTICIPANTS The PD REHAB Trial was a multicenter, open-label, parallel group, controlled efficacy trial. A total of 762 patients with mild to moderate PD were recruited from 38 sites across the United Kingdom. Recruitment took place between October 2009 and June 2012, with 15 months of follow-up. INTERVENTIONS Participants with limitations in activities of daily living (ADL) were randomized to physiotherapy and occupational therapy or no therapy. MAIN OUTCOMES AND MEASURES The primary outcome was the Nottingham Extended Activities of Daily Living (NEADL) Scale score at 3 months after randomization. Secondary outcomes were health-related quality of life (assessed by Parkinson Disease Questionnaire–39 and EuroQol-5D); adverse events; and caregiver quality of life. Outcomes were assessed before trial entry and then 3, 9, and 15 months after randomization. RESULTS Of the 762 patients included in the study (mean [SD] age, 70 [9.1] years), 381 received physiotherapy and occupational therapy and 381 received no therapy. At 3 months, there was no difference between groups in NEADL total score (difference, 0.5 points; 95%CI, −0.7 to 1.7; P = .41) or Parkinson Disease Questionnaire–39 summary index (0.007 points; 95%CI, −1.5 to 1.5; P = .99). The EuroQol-5D quotient was of borderline significance in favor of therapy (−0.03; 95%CI, −0.07 to −0.002; P = .04). The median therapist contact time was 4 visits of 58 minutes over 8 weeks. Repeated-measures analysis showed no difference in NEADL total score, but Parkinson Disease Questionnaire–39 summary index (diverging 1.6 points per annum; 95%CI, 0.47 to 2.62; P = .005) and EuroQol-5D score (0.02; 95%CI, 0.00007 to 0.03; P = .04) showed small differences in favor of therapy. There was no difference in adverse events. CONCLUSIONS AND RELEVANCE Physiotherapy and occupational therapy were not associated with immediate or medium-term clinically meaningful improvements in ADL or quality of life in mild to moderate PD. This evidence does not support the use of low-dose, patient-centered, goal-directed physiotherapy and occupational therapy in patients in the early stages of PD. Future research should explore the development and testing of more structured and intensive physical and occupational therapy programs in patients with all stages of PD